E -Hu Liu

E -Hu Liu

Auto-generated profile, based on publicly available information

E -Hu Liu

School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2016 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
LDLi Duan
Li Duan
LDLi-Li Dou
Li-Li Dou
LGLong Guo
Long Guo
PLPing Li
Ping Li
ELE-Hu Liu
E-Hu Liu

3 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SZSu-Ling Zeng
Su-Ling Zeng
SLShang-Zhen Li
Shang-Zhen Li
PXPing-Ting Xiao
Ping-Ting Xiao
YCYuan-Yuan Cai
Yuan-Yuan Cai
CCChu Chu
Chu Chu
ELE-Hu Liu
E-Hu Liu
Metabolic syndrome (MetS) is intricately linked to dysregulation of gut microbiota and host metabolomes. Here, we first find that a purified citrus polymethoxyflavone-rich extract (PMFE) potently ameliorates high-fat diet (HFD)–induced MetS, alleviates gut dysbiosis, and regulates branched-chain amino acid (BCAA) metabolism using 16S rDNA amplicon sequencing and metabolomic profiling. The metabolic protective effects of PMFE are gut microbiota dependent, as demonstrated by antibiotic treatment and fecal microbiome transplantation (FMT). The modulation of gut microbiota altered BCAA levels in the host serum and feces, which were significantly associated with metabolic features and actively responsive to therapeutic interventions with PMFE. Notably, PMFE greatly enriched the commensal bacterium Bacteroides ovatus, and gavage with B. ovatus reduced BCAA concentrations and alleviated MetS in HFD mice. PMFE may be used as a prebiotic agent to attenuate MetS, and target-specific microbial species may have unique therapeutic promise for metabolic diseases.

27 June 2023 in Science Bulletin
Verified
Journal Article
Open access
ZJZheng-Meng Jiang
Zheng-Meng Jiang
SZSu-Ling Zeng
Su-Ling Zeng
THTian-Qing Huang
Tian-Qing Huang
YLYang Lin
Yang Lin
FWFang-Fang Wang
Fang-Fang Wang
ELE-Hu Liu
E-Hu Liu
Gut microbiota dysbiosis is associated with the development of rheumatoid arthritis (RA). Sinomenine (SIN) is an effective immunosuppressive and anti-inflammatory drug used for treating RA, but how SIN regulates gut microbiota to alleviate RA remains underexplored. To identify the critical gut microbial species and microbial metabolites associated with the RA-protective effects of SIN, the microbiota-dependent anti-RA effects of SIN were assessed by 16S rRNA gene sequencing, antibiotic treatment, and fecal microbiota transplantation. Metabolomics analysis, transcriptional analysis, and targeted bacteria/metabolites gavage were conducted to explore how SIN regulates gut microbiota to reduce the severity of RA. SIN could restore intestinal microbial balance by mainly modulating the abundance of Lactobacillus, and significantly relieve collagen-induced arthritis (CIA) symptoms in a gut microbiota-dependent manner. SIN significantly elevated microbial tryptophan metabolites indole-3-acrylic acid (IA), indole-3-propionic acid (IPA), and indole-3-acetic acid (IAA). Tryptophan metabolites supplementation could activate aryl hydrocarbon receptor (AhR) and regulate Th17/Treg balance in CIA rats. Intriguingly, SIN relieved the arthritis symptoms involving the enrichment of two beneficial anti-CIA Lactobacillus species, L. paracasei and L. casei by mono-colonization. The promising therapeutic function of SIN was mostly attributed to the activation of AhR by explicitly targeting the Lactobacillus and microbial tryptophan metabolites. The intestinal bacterium L. paracasei and L. casei may be used to reduce the severity of CIA.

1 February 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
BZBo Zhuang
Bo Zhuang
LDLi-Li Dou
Li-Li Dou
PLPing Li
Ping Li
ELE-Hu Liu
E-Hu Liu


1 November 2017 in Food Chemistry
Verified
Journal Article
Closed access
LDLi Duan
Li Duan
LDLi-Li Dou
Li-Li Dou
KYKe-Yun Yu
Ke-Yun Yu
LGLong Guo
Long Guo
CBChen Bai-Zhong
Chen Bai-Zhong
ELE-Hu Liu
E-Hu Liu